This is How Key Players are Dominating Global Clinical Trial Management System Industry

 Major Growth Driving Factors:

The growth of the Clinical Trial Management System Market is driven by increasing number of clinical trials, and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market growth.

Projected Surge in Revenue Generation:

The clinical trial management system market is projected to reach USD 1,590 million by 2025, at a CAGR of 14.7 % during the forecast period.

Global Leading Companies Operating in This Industry:

# Oracle Corporation (US)
# Medidata Solutions (US)
# Parexel International (US)
# Bioclinica (US)
# IBM (US) among others.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

More About Leading Companies & Growth Strategies Adopted by Them:

As of 2019, Oracle Corporation (US) holds the leading position in the global CTMS market. It has a wide range of CTMS solutions and a broad customer base in over 145 countries. It primarily focuses on capability expansion and partnerships & collaborations to sustain its leading position in the CTMS market.

In the past three years, the company partnered or collaborated with several industry stakeholders for collaborative research that utilizes CTMS solutions, such as FHI Clinical (US). Besides product launches, the company also acquired goBalto (aimed to strengthen its services & customer assistance capabilities across its customer base) and established the Oracle Cloud EU Center (Germany) to expand its market presence in Europe.

Medidata Solutions (US) is a leader in the global CTMS market. The company offers cloud-based (software-as-a-service) CTMS across the globe. It primarily focuses on partnerships and collaborations to expand its market presence. For instance, the company signed a research partnership with several industry stakeholders during 2016–2020, including Hanmi Pharma (South Korea) and GSK (UK).

Major Growth Strategies Adopted:

The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their market shares in clinical trial management system market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Acquisitions were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

Request Sample Pages for More Details@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

Recent Developments:

# In June 2019, Parexel International Corporation (US) launched an enhanced integrated outsourcing delivery model for functional service provider (FSP) services at the DIA 2019 Global Annual Meeting in San Diego, US.

# In May 2019, Bio-optronics (US) launched three products to the CCTrialSuite basket application—CCeSource, CCeReg & CCeConsent.

# In June 2018, Bioclinica (US) launched eClinical Solution namely the SMART Technology Suite.

Read More About the Related Reports, Here:

CRO Services Market - Global Forecast to 2027

Clinical Decision Support Systems (CDSS) Market - Global Forecast to 2027

Clinical Trial Management System Market worth $1,590 Million by 2025

 Overview:

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Expected Revenue Growth:

The clinical trial management system market is projected to reach USD 1,590 Million by 2025 from USD 801 Million in 2020, at a CAGR of 14.7 %  the forecast period.

Growth Boosting Factors:

Growth in this market is primarily driven by rising industry-academia collaborations, the increasing number of clinical trials, rising technology adoption, and government support for research trials.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

Data Triangulation:

After deriving the overall clinical trial management system market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Global Industry Dynamics:

Based on Deployment mode, enterprise-wide segment to register significant growth during the forecast period.

Based on the deployment mode, the clinical trial management system market is segmented into enterprise-wide and on-site CTMS. The enterprise-wide segment accounted for the largest share in the year 2019. The large share of this segment can be attributed to its widespread adoption by the majority of end-users due to its benefits.

Based on Delivery mode, the web-based segment is expected to account for the largest share of the clinical trial management system  market in 2019

Based on the delivery mode, the clinical trial management system market is segmented into web-based (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) CLINICAL TRIAL MANAGEMENT SYSTEM . Among these, the trauma and hairline fractures sub-segment dominated the market in 2019.  The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, and time and cost-efficiency.

The software segment is expected to account for the largest share during the forecast period

Based on product & service, the clinical trial management system market is segmented into software and services. Rising R&D expenditure, an increasing number of clinical trials, and the growing adoption of clinical trial management solutions are some of the key factors driving the growth of the software market.

The small & mid-sized pharma-biotech companies segment is expected to register the highest CAGR during the forecast period

Based on end-users, the clinical trial management system market has been segmented based on end-user category—large pharma-biotech companies, small & mid-sized pharma-biotech companies, CROs, medical device manufacturers, and other end users. Due to rising pressure of R&D costs, outcomes-based reimbursement, and stricter regulations imposed on large pharma companies, a part of their R&D functions is outsourced to smaller pharmaceutical companies, which increases the growth of companies in this category.

Geographical Growth Scenario:

North America is expected to dominate the global clinical trial management system  market in 2019

North America, comprising the US and Canada, accounted for the largest share of the clinical trial management system market in 2019. The large share of this region can primarily be attributed to factors such as the high number of ongoing clinical trials (especially in the US), the presence of leading players from both the demand and supply sides, and the presence of a favorable government funding scenario for clinical research.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

Key Players:

Oracle Corporation (US), Medidata Solutions (US), Parexel International (US), Bioclinica (US), and IBM (US), Bio-Optronics (US), Datatrak (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Advarra Technology Solutions (US), MedNet Solutions (US), ArisGlobal (US), DZS Clinical Services (US), Crucial Data Solutions (US), Ennov (France), DataStat (US), and RealTime Software Solutions LLC (US) among others are some of the major players operating in the global clinical trial management system market.

Clinical Trial Management System - Global Industry Growth Expectations

A clinical trial management system (CTMS) is a software system used to manage clinical trials. It streamlines the clinical trial process and optimizes operational efficiency. This helps reduce the overall cost of conducting clinical trials. CTMS assist companies that conduct clinical trials such as CROs; medical device, pharmaceutical and biotechnology companies to plan, track, and manage clinical trials and their progress.

Following are the Major Objectives of this Study:

# To define, describe, segment, and forecast the global clinical trial management systems market on the basis of components, type, delivery mode, end user, and region.

# To provide detailed information regarding the major factors influencing the overall market growth (drivers, restraints, opportunities, challenges, and trends) across individual geographies

# To analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the overall market

# To analyze growth opportunities in the global clinical trial management system industry for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to the four key regions—North America (US, Canada), Europe (Germany, UK, France, and RoE), Asia Pacific (China, Japan, India, and RoAPAC), and the Rest of the World (RoW)

# To profile the key players in the global clinical trial management systems market and comprehensively analyze their market shares and core competencies2

# To track and analyze competitive developments such as product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the CTMS solutions market

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

Target Audience:

# Healthcare IT service providers

# Pharmaceutical/biopharmaceutical companies

# Clinical research organizations

# Research and development (R&D) companies

# Medical device companies

# Business research and consulting service providers

# Academic medical centers/universities/hospitals

Factors Influencing Global Growth:-

Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets.

Restraints:

# Budget constraints

# Limited awareness among researchers about the advantages of CTMS solutions

Opportunities

# Increased outsourcing of clinical trial processes by industrial researchers to Asian countries/ developing countries CROs

# Increasing use of platform-as-a-service (PaaS) and mobile computing

Challenges:

# Lack of skilled professionals

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global clinical trial management system market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

Geographical Growth Scenario:

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

Leading Market Players:

# Oracle (US)

# Medidata Solutions (US)

# PAREXEL (US)

# Bioclinica (US)

# Bio-Optronics (US)

# IBM (US) and many more…

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market. Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.